The Startup Behind The Pill For Sleep Apnea Raises $192 Million In IPO

Apnimed got a new CEO in anticipation of its public offering. Its pill for sleep apnea could receive approval early next year.

forbes.com

Opinion | Why Do We Tolerate Elon Musk’s Racist Commentary?

Why does the owner of X get a pass for what he says and does there?

nytimes.com

The Startup Using AI To Make Hearing Aids Better

In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby Care’s business getting payment for caregivers, J&J’s $5.5 billion talc settlement, Scribe Thera...

forbes.com

Peptides May Soon Be Legal. These Companies Are Ready To Cash In

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.

forbes.com

Axon Says AI Police Reports Save Time. Public Records Show They Get Facts Wrong

More than 600,000 police reports have been written with help from Axon’s AI tools. Public records obtained by Forbes show that they can introduce errors that cops have to spend time editing out.

forbes.com

OpenAI Sued Over ChatGPT’s ‘Dangerous’ Health Advice

The case appears to be the first to argue that a chatbot’s advice harmed someone seeking guidance about a medical condition.

nytimes.com

The Potential Havoc Of Generic Drug Tariffs

In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company...

forbes.com

Peptides May Soon Be Legal. These Companies Are Ready To Cash In

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.

forbes.com

They Were Charged With Assaulting ICE Agents. The Cases Are Crumbling.

The Trump administration has lost or abandoned hundreds of criminal cases against protesters and immigrants, a Times investigation found.

nytimes.com

Trump Made Even More Money Than You Thought Last Year

America’s salesman-in-chief capitalized on the most lucrative pitch of his life. Now Trump is selling something else—the myth that he doesn’t know how he made so much.

forbes.com

Founder Of $1 Billion Cancer Care Startup Steps Down As CEO

In this week’s edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million raise, and more.

forbes.com

A 'Holy Grail' Sleep Apnea Pill Could Be On The Market Next Year

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

forbes.com

Israel’s Palantir Rival Is Selling $1 Million Spy Vans To U.S. Cops

Cognyte, which sells technology to snoop on phone locations largely in Israel and Europe, is making inroads in America by tricking out trucks with spy tech.

forbes.com

How Marco Rubio Is Running Venezuela From Afar

The secretary of state effectively controls Venezuela’s finances, the distribution of its natural resources and its government. His grip on the country is a vivid manifestation of American power in th...

nytimes.com

'Huge Red Flag’: The Case of the Redacted SEC Conflict of Interest Waiver

Ethics officials granted a waiver to an official who holds stocks in major technology companies.

notus.org

Boom Times For Autoimmune Disease Therapies

In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.

forbes.com

‘I’m Now Broke’: These Investors Lost Billions Buying Trump Stocks And Crypto

Desperate to rebuild his fortune, Donald Trump asked his political supporters to become his business partners. Those who trusted him most got hurt the worst.

forbes.com

Exclusive | Obamacare Insurers Seek Big Rate Hikes, Again

Affordable Care Act plans are citing rising healthcare costs and falling enrollment.

wsj.com

How OpenAI Plans To Win Over Doctors, Patients And Hospitals

The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to make sure ChatGPT is accurate enough for the millions of people who already...

forbes.com

Why Axsome Stock Has Doubled In Nine Months

In this week’s edition of InnovationRx, we look at Axsome’s growing pipeline, HistoSonics innovative cancer treatment, state litigation over Medicaid work requirements, and more.

forbes.com

In San Francisco, Even $180,000 Tech Salaries Are No Longer Enough

nytimes.com

These 29-Year-Olds’ AI Chatbot For Scheduling Doctor Visits Is Now Worth $1.2 Billion

Scheduling doctor appointments is its own form of hell for both physicians and patients. Assort Health’s AI fix helped it raise its third venture round in 14 months.

forbes.com

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.

statnews.com

This Startup Says It Saves Medicare More Than $2 Million A Week

Cadence reached a $1.2 billion valuation by using AI to track seniors’ chronic health conditions and improve their care.

forbes.com

Marjane Satrapi, author of 'Persepolis,' dies at 56

The Iranian-French cartoonist and filmmaker was perhaps most well-known for the graphic memoir, and subsequent film, about her life during the Iranian revolution in 1979.

npr.org

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 million more VC funding at a $3.4 billion valuation, Forbes h...

forbes.com

AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork

In this week’s edition of InnovationRx, we look at breakthroughs from ASCO, Harrison.ai's U.S. expansion, Clear's move into healthcare and more.

forbes.com

White House Seeks to Impose Political Test on Billions in Federal Grants

nytimes.com